Gilead Sciences Statistics and Revenue Totals for 2024
Last Updated on: January 14th, 2024
Here are a few of the most interesting Gilead Sciences statistics and facts I was able to dig up including restaurant count, revenue totals and employee counts. As always, be sure to check back in the future as I will be updating this post as new and updated stats become available.
Critical sections of this article:
- Gilead Sciences Facts
- Gilead Sciences Statistics
- Gilead Sciences Employee Count
- Gilead Sciences Revenue Totals
Gilead Sciences Facts
Here is pretty much everything you ever wanted to know about Gilead Sciences.
- Website: Official Website
- Year Founded: 1987
- Headquarters: Foster City, CA
- Founder(s): Michael Riordan
- Current Chief Executive: John Milligan
- Subsidiaries / Brands: Atripla, Biktarvy, Complera, Descovy, Emtriva, Genvoya, Odefsey, Stribild, Truvada, Tybost, Viread, Epclusa, Harvoni, Hepsera, Sovaldi, Vemlidy, Viread, Vosevi, Yescarta, Zydelig, Letairis, Lexiscan, Ranexa, Cayston, Tamiflu, AmBisome, Macugen, Biktarvy, Remdesivir, Filgotnib, Cilofexor, GLPG-1690, KTE-X19, Axi-cel,
Gilead Sciences, Inc. is a leading biopharmaceutical company headquartered in Foster City, California. Founded in 1987, Gilead has established itself as a pioneer in the field of antiviral drug development and is renowned for its contributions to the treatment of infectious diseases, particularly HIV/AIDS, hepatitis B and C, and more recently, the development of treatments for other serious medical conditions.
One of Gilead’s most notable achievements was the development of the revolutionary antiretroviral medication Truvada, which has been used as a key component in HIV prevention strategies, such as pre-exposure prophylaxis (PrEP). The company’s dedication to research and development has also led to breakthrough treatments for hepatitis C, transforming the landscape of hepatitis treatment.
Gilead Sciences Statistics
Gilead Sciences Revenue Totals
Gilead annual revenue:
- 2022: $27.281 billion
- 2021: $27.305 billion
- 2020: $24.689 billion
- 2019: $22.449 billion
- 2018: $22.127 billion
- 2017: $26.107 billion
- 2016: $30.390 billion
- 2015: $32.639 billion
- 2014: $24.890 billion
- 2013: $11.202 billion
Gilead annual net income:
- 2022: $4.592 billion
- 2021: $6.225 billion
- 2020: $123 million
- 2019: $5.364 billion
- 2018: $5.455 billion
- 2017: $4.644 billion
- 2016: $13.488 billion
- 2015: $18.106 billion
- 2014: $12.059 billion
- 2013: $3.057 billion
Additional Gilead Sciences Statistics
Number of countries Gilead has operations in:
Last updated 9/1/19
Please note that some of these numbers are easier to find than others. A few of these Gilead Sciences statistics come from their own reports, but some are based on news reports and not official company tallies. No information contained on DMR should be relied upon to make investment decisions. Basically, this is the best I can find and I don’t guarantee anything to be 100%.
Related Categories:
Related Tags:
